Skip Navigation
Medical University | MUSC Hospital | Directory | A-Z Index

MUSC logo


   | MUSC Medical Center Residency Program | Programs | PGY2 | Solid Organ Transplant


Nicole Pilch, PharmD, BCPS
Clinical Pharmacy Specialist, Solid Organ Transplant
Clinical Assistant Professor
Solid Organ Transplant Residency Program Director
The Residency Experience
Learning Experiences





The MUSC Medical Center is a 709-bed tertiary care academic medical center providing care for patients of Charleston and throughout the state of South Carolina. In addition to general medical and surgical services, MUSC offers a variety of specialty services including cardiothoracic, transplant and neurosurgery, level I trauma center, digestive disease, psychiatry and level III neonatal intensive care. The medical center is comprised of four hospitals, Ashley River Tower, Children's Hospital, Institute of Psychiatry, and University Hospital. Outpatient facilities include the Hollings Cancer Center, Ashley River Tower Clinics, Rutledge Tower Clinics, Family Medicine Center and affiliated faculty practice ambulatory care centers.

The MUSC Transplant Center performs over 300 solid organ transplants annually, including kidney, liver, pancreas, heart, and lung. The center has been nationally recognized for providing low-cost, high quality care through a multidisciplinary team approach. Clinical Pharmacy Services has been a vital member of the transplant team since the programs early beginnings, and continues to have an important role in assuring optimal care for transplant patients.

The solid organ transplant pharmacy residency at the Medical University of South Carolina is a specialized residency consisting of 12 months of training and experience. The program allows sufficient flexibility to adapt to the interests and needs of the individual resident, yet provides the basic foundation for quality clinical practice in transplant. Upon completion of this comprehensive program, the resident will be prepared to enter a clinical practice position or a fellowship program.

The Department of Pharmacy Services provides service to patients on a 24 hour basis through multiple inpatient and ambulatory pharmacies to fulfill the department’s mission, vision, and goals of providing optimal pharmaceutical care to all patients. Comprehensive clinical pharmacy services are provided by full-time transplant clinical pharmacy specialists on a 24 hour basis. Rutledge Tower and Ashley River Tower Pharmacies provide outpatient services for the solid organ transplant patients.


The Postgraduate Year Two (PGY2) Solid Organ Transplant Pharmacy Residency Program is designed to develop accountability; practice patterns; habits; and expert knowledge, skills, attitudes, and abilities in the respective advanced area of pharmacy practice. The Solid Organ Transplant Pharmacy Residency Program builds upon the broad-based competencies achieved in a PGY1 residency, deepening the resident’s ability to provide care in the most complex of cases or in the support of care through practice leadership. Therefore, Solid Organ Transplant
Pharmacy Residency Program provides residents with opportunities to function independently as practitioners by conceptualizing and integrating accumulated experience and knowledge and transforming both into improved medication therapy for patients. A resident who completes successfully an accredited PGY2 Solid Organ Transplant Pharmacy Residency Program should possess competencies that enable attainment of board certification in the practice area, i.e., BCPS.

Additionally, The MUSC PGY2 Solid Organ Transplant Pharmacy Residency is committed to developing expert clinical specialists. Residents who graduate from our program are prepared to enter clinical practice or assume a faculty role within a college of pharmacy.


Specific residency goals and objectives will be established in the beginning of the residency modified according to the resident’s interests and previous experiences and advisor input. To meet the purpose of the residency, the resident will advance to achieve the following outcomes:

  • Serve as an authoritative resource on the optimal use of medications in recipients of a solid organ transplant.
  • Optimize the outcomes of transplant patients by promoting and/or providing evidence-based medication therapy as an integral member of an interdisciplinary team in acute and ambulatory care settings.
  • Manage and improve the medication-use process in transplant patient care areas.
  • Demonstrate leadership and practice management skills.
  • Demonstrate excellence in the provision of training or educational activities about transplant-related medications for health care professionals and health care professionals in training.
  • Conduct transplant research.
  • Contribute to formulary decisions regarding transplant-related medications.
  • Publish on transplant-related topics.
  • Function effectively in transplant settings participating in clinical investigations.
  • Demonstrate skills required to function in an academic setting.

The Residency Experience

The breadth of experience provided by this residency program will allow successful candidates to work in any facet of solid organ transplant. Residents will become experts in immunosuppressant, infectious disease, internal medicine and critical care pharmacotherapy. The high level of clinical practice, which is established by the program’s preceptors, allows the resident sufficient autonomy to become an independent practitioner. Residents have the opportunity to care for inpatient adult and pediatric solid organ transplant recipients, as well as, participate in ongoing careof transplant recipients in various ambulatory care clinics. Specifically, the management of end organ diseases of the liver, kidney, pancreas, and heart, acute and chronic management of immunosuppression, acute and chronic management of the complications and toxicities associated with the use of immunosuppressants, acute and chronic monitoring and management of the various degrees of organ dysfunction associated with post-transplant patients, management of common comorbid conditions transplant patients have or may develop, and management of the acute and chronic infectious complications associated with transplantation and immunosuppression will be emphasized. The resident will also have various levels of involvement in clinical research, department of pharmacy service projects, and teaching (both didactically and experiential) of doctor of pharmacy students and medical house staff.

Learning Experiences:

Learning Experiences
Orientation (includes orientation to inpatient staffing)
1 month
Adult and pediatric inpatient solid organ abdominal transplant
4 months
Adult and pediatric ambulatory solid organ abdominal transplant
2-3 months
Adult inpatient and outpatient heart and lung transplant1-2 months
Electives (any of the above and/or Transplant Nephrology) Medical Intensive Care Unit, Medical Surgical Intensive Care unit) Bone Marrow Transplantation2-4 months



  • Didactic lectures in transplant related areas within the college of pharmacy, including the Immunology/Transplantation elective
  • In-services to pharmacy, medical, and nursing staff (inpatient and outpatient).
  • Co-preceptor of Pharm.D. students and PGY1 residents on elective Transplant rotations.
  • Presentations at the Transplant Conference and national transplant meetings.


James Fleming, PharmD, BCPSJoseph Mazur, PharmD, BCPS
David J. Taber, PharmD, BCPSWendy Bullington, PharmD, BCPS
Holly Meadows, PharmD, BCPSWalter Uber, BS, PharmD

On-site Interviews Will Be Required

Starting in 2012 the MUSC Pharmacy Program will be using the PhORCAS Application System through ASHP.  Please submit all application materials through the applicant portal on ASHP's website.  The deadline for receipt of a complete application packet is December 31st.  Applicants can begin submitting materials through PhORCAS on November 19.  Complete applications include the following:

  • Letter of intent (uploaded with application)
  • Curriculum vitae (uploaded with application)
  • Three letters of reference completed by health professionals who can attest to the applicant’s practice abilities and aptitudes (uploaded directly from the authors beginning on November 19)
  • At least one letter must be from an immediate supervisor (if applicable - for PGY1 only)
  • At least one letter must be from a clinical preceptor
  • Official transcripts of all professional pharmacy education
  • Class rank (in a sealed envelope from Dean's Office)
  • List of Rotations completed.

The application, letter of intent and curriculum vitae should be submitted via the PhORCAS applicant portal.  Letters of reference should also be submitted via PhORCAS Reference Portal using the ASHP Reference Template no later than December 31 directly from the authors.  For further information, please see application information.

For further information contact:

Residency Program Director
Nicole Pilch, PharmD, BCPS
Clinical Pharmacy Specialist, Solid Organ Transplant
Medical University of South Carolina
150 Ashley Avenue
Charleston, SC 29425
Office: (843) 792-3702
Fax: (843) 792-1549

Introduction|Purpose|Outcomes|The Residency Experience|Learning Experiences|Teaching|Preceptors
December 4, 2013
MUSC Residency In The News
Resident Seminar
RITE, Current Topics & Discussion Series
Quick Links
Who's On What (WOW)

Alumni & Resident Newsletter
The Bridge